ArticleMedical oncology (Northwood, London, England)2022

Unique combinations of epigenetic modifiers synergistically impair the viability of the U87 glioblastoma cell line while exhibiting minor or moderate effects on normal stem cell growth.

Arshak R Alexanian et al.PubMed ↗Publisher ↗

No numbers read from the abstract.